We are live on ! Find out more
BI

BVF Inc Portfolio holdings

AUM $3.14B
1-Year Est. Return 249.53%
This Fund
S&P 500
This Quarter Est. Return
+18.18%
1 Year Est. Return
+249.53%
3 Year Est. Return
+690.11%
5 Year Est. Return
+1,011.36%
10 Year Est. Return
+22,702.25%
AUM
$478M
AUM Growth
-$35.8M
Cap. Flow
-$112M
Cap. Flow %
-23.36%
Top 10 Hldgs %
71.33%
Holding
31
New
1
Increased
7
Reduced
12
Closed
1

Top Buys

Rank Stock Value
1
VTAE
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
+$11.1M
2
QLTI
QLT Inc
QLTI
+$6.17M
3
FWP
Forward Pharma A/S American Depositary Shares
FWP
+$2.9M
4
LITS
Lite Strategy Inc
LITS
+$2.69M
5
ARQL
Arqule Inc
ARQL
+$2.31M

Top Sells

Rank Stock Value
1
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$45.8M
2
LGND icon
Ligand Pharmaceuticals
LGND
+$36.4M
3
ARRY
Array Biopharma Inc
ARRY
+$16.8M
4
FPRX
Five Prime Therapeutics, Inc.
FPRX
+$8.16M
5
XENE icon
Xenon Pharmaceuticals
XENE
+$4.19M

Sector Composition

Rank Sector Weight
1 Healthcare 62.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APTO
26
DELISTED
Aptose Biosciences, Inc.
APTO
$907K 0.19%
370
– –
VXRT
27
DELISTED
Vaxart
VXRT
$807K 0.17%
31,889
-7,738
-20% -$213K
SPHS
28
DELISTED
Sophiris Bio, Inc.
SPHS
$614K 0.13%
1,060,283
– –
KBIO
29
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
$569K 0.12%
145,250
– –
ANTH
30
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
– –
-69,953
Closed -$884K
1
2

Similar funds

GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.12B AUM 12.93% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.12B AUM 25.62% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return

BVF Inc's Q1 2015 Portfolio in Review

As of Q1 2015, BVF Inc held 31 positions worth $478M, down 7% from $514M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

BVF Inc withdrew a net $112M in Q1 2015, closing 1 position and reducing 12 holdings. Its most notable exit was Anthera Pharmaceuticals, Inc., an estimated $884K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 63% of assets, down from 71% a quarter earlier.

Against the trend, BVF Inc opened a new position in Lite Strategy Inc worth $1.07M.

  • BVF Inc's largest Q1 2015 buy was Lite Strategy Inc: 30,000 shares worth $1.07M.
  • BVF Inc added most to VITAE PHARMACEUTICALS INC COMMON STOCK in Q1 2015, an estimated $11.1M increase.
  • BVF Inc's biggest Q1 2015 reduction was Ironwood Pharmaceuticals, cutting an estimated $45.8M.
  • BVF Inc fully exited Anthera Pharmaceuticals, Inc. in Q1 2015, selling an estimated $884K.
  • BVF Inc's ten largest holdings make up 71% of its $478M portfolio in Q1 2015.
  • BVF Inc opened 1 new position and closed 1 in Q1 2015.
  • BVF Inc's portfolio value fell 7% quarter-over-quarter to $478M.

Based on BVF Inc's 13F filing for Q1 2015, filed 15 May 2015.